Literature DB >> 4376472

A modified method for phenotyping of hyperlipoproteinaemia on agarose electrophoresis.

A Van Melsen, Y De Greve, F Vanderveiken, M Vastesaeger, V Blaton, H Peeters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4376472     DOI： 10.1016/0009-8981(74)90299-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  6 in total

1.  Apolipoprotein E phenotypes and hyperlipidemia.

Authors:  G Utermann; I Kindermann; H Kaffarnik; A Steinmetz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Apolipoprotein E phenotypes in patients with myocardial infarction.

Authors:  G Utermann; A Hardewig; F Zimmer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.

Authors:  G Feussner; M Eichinger; R Ziegler
Journal:  Clin Investig       Date:  1992-11

4.  A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia.

Authors:  G Feussner; J Dobmeyer; H J Gröne; S Lohmer; S Wohlfeil
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

5.  Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI.

Authors:  G Utermann; A Steinmetz; R Paetzold; J Wilk; G Feussner; H Kaffarnik; C Mueller-Eckhardt; D Seidel; K H Vogelberg; F Zimmer
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.

Authors:  G Feussner; A Wagner; B Kohl; R Ziegler
Journal:  Clin Investig       Date:  1993-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.